Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUR.L Regulatory News (SUR)

  • There is currently no data for SUR

Director Dealing

25 Nov 2019 17:15

RNS Number : 5993U
Sureserve Group PLC
25 November 2019
 

Sureserve Group plc

("Sureserve" or the "Group")

Director Dealing

 

Sureserve was notified today that on 22 November 2019, Harwood Capital LLP purchased 324,711 ordinary shares in Sureserve ("Ordinary Shares") at a price of 29 pence per Ordinary Share.

 

Christopher Mills, Non-Executive Director of Sureserve, is deemed to be person discharging managerial responsibilities at Harwood Capital LLP and is therefore deemed to have an interest in 30,489,711 Ordinary Shares of Sureserve representing 19.18% of the issued share capital of Sureserve.

 

 

Enquiries

Sureserve

Financial Public Relations

Bob Holt, Chairman, 07778 798816

Camarco

Peter Smith, Chief Financial Officer

Ginny Pulbrook

Telephone: 020 3961 5210

 

Tom Huddart

Telephone: 020 3757 4992

 

Shore Capital

Antonio Bossi

Mark Brown

Telephone: 020 7408 4050

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Harwood Capital LLP as investment manager to itself and two other companies

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Christopher Mills, non-exec director of the issuer and director and shareholder of the other entities

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Sureserve Group plc

b)

 

LEI

 

 

213800FHUTNVX8LWPH50

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.10 each

Identification code

GB00BSKS1M86

 

b)

 

Nature of the transaction

 

 

Share purchase

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.29

324,711

d)

 

Aggregated information

- Aggregated volume

324,711

- Price

£94,166.19

e)

 

Date of the transaction

 

 

22 November 2019

f)

 

Place of the transaction

 

 

London Stock Exchange

 

Notes to editors

Sureserve is a leading compliance and energy support services group that performs critical functions in homes, public and commercial buildings, with a focus on clients in the UK public sector and regulated markets. Services are delivered through two divisions: Compliance and Energy Services.

The Group was founded in 1988 and is headquartered in Basildon. It currently employs some 2,000 staff from 23 offices across the UK.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDELFLKFFFFBZ
Date   Source Headline
4th Apr 202210:18 amRNSHolding(s) in Company
31st Mar 20227:00 amRNSExercise of Options and Total Voting Rights
22nd Mar 20221:31 pmRNSResult of AGM
22nd Mar 20221:14 pmRNSIssue of Equity and Total Voting Rights
15th Feb 20224:56 pmRNSAnnual Financial Report & Notice of AGM
1st Feb 20223:30 pmRNSExercise of Options and Total Voting Rights
1st Feb 20227:00 amRNS10-year £20 million win for Tower Hamlets Homes
25th Jan 20227:00 amRNSPreliminary Results
23rd Dec 20217:00 amRNSGrant of Options
16th Dec 20218:37 amRNSExercise of Options and Total Voting Rights
14th Dec 20217:00 amRNSAppointment of Interim CFO
9th Dec 20217:00 amRNSIssue of Shares and Total Voting Rights
8th Dec 20217:00 amRNSAcquisition of CorEnergy Limited
2nd Dec 20213:05 pmRNSChange of Registered Office
19th Nov 20214:01 pmRNSHolding(s) in Company
16th Nov 20217:00 amRNSHolding(s) in Company
4th Nov 20217:00 amRNSAppointment of Chief Executive Officer
7th Oct 202111:24 amRNSDirector/PDMR Shareholding
7th Oct 20217:00 amRNSTrading Update
20th Sep 20215:54 pmRNSExercise of Options and Total Voting Rights
23rd Aug 20217:00 amRNS10-year contract extension worth £140m
28th Jul 20212:27 pmRNSDirector/PDMR Shareholding
23rd Jul 20218:46 amRNSExercise of Options and Total Voting Rights
8th Jul 20218:45 amRNS8-year contract worth £36 million for PA Housing
18th Jun 20218:27 amRNSExercise of Options and Total Voting Rights
7th Jun 202111:27 amRNSTransaction by Director/PDMR
7th Jun 20217:00 amRNSExercise of Options and Total Voting Rights
26th May 20217:00 amRNSAppointment of Chairman
20th May 20215:49 pmRNSHolding(s) in Company
19th May 20215:07 pmRNSHolding(s) in Company
18th May 20217:00 amRNSInterim Results
26th Apr 202111:21 amRNSExercise of Options and Total Voting Rights
16th Apr 20213:42 pmRNSHolding(s) in Company
15th Apr 202112:00 pmRNSDirector/PDMR Shareholding
12th Apr 20213:40 pmRNSNotice of Interim Results
12th Apr 20217:00 amRNSExercise of Options and Total Voting Rights
6th Apr 202111:00 amRNSExercise of Options and Total Voting Rights
30th Mar 20214:35 pmRNSTransaction by Director/PDMR
30th Mar 20211:44 pmRNSTransaction by Director/PDMR
18th Mar 202112:30 pmRNSResult of AGM
18th Mar 202111:06 amRNSSecond Price Monitoring Extn
18th Mar 202111:01 amRNSPrice Monitoring Extension
18th Mar 20219:05 amRNSSecond Price Monitoring Extn
18th Mar 20219:00 amRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSDirectorate Change
1st Mar 20217:06 amRNSTotal Voting Rights
19th Feb 20217:00 amRNSPosting of Accounts and AGM
12th Feb 20213:30 pmRNSHolding(s) in Company
8th Feb 20217:00 amRNSHolding(s) in Company
2nd Feb 20217:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.